These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16469868)

  • 1. Bcr-Abl reduces endoplasmic reticulum releasable calcium levels by a Bcl-2-independent mechanism and inhibits calcium-dependent apoptotic signaling.
    Piwocka K; Vejda S; Cotter TG; O'Sullivan GC; McKenna SL
    Blood; 2006 May; 107(10):4003-10. PubMed ID: 16469868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL.
    Horita M; Andreu EJ; Benito A; Arbona C; Sanz C; Benet I; Prosper F; Fernandez-Luna JL
    J Exp Med; 2000 Mar; 191(6):977-84. PubMed ID: 10727459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase.
    Pattacini L; Mancini M; Mazzacurati L; Brusa G; Benvenuti M; Martinelli G; Baccarani M; Santucci MA
    Leuk Res; 2004 Feb; 28(2):191-202. PubMed ID: 14654084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
    Hoover RR; Gerlach MJ; Koh EY; Daley GQ
    Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion.
    Keeshan K; Cotter TG; McKenna SL
    Leukemia; 2002 Sep; 16(9):1725-34. PubMed ID: 12200687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway.
    Naughton R; Quiney C; Turner SD; Cotter TG
    Leukemia; 2009 Aug; 23(8):1432-40. PubMed ID: 19295548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors.
    Kuribara R; Honda H; Matsui H; Shinjyo T; Inukai T; Sugita K; Nakazawa S; Hirai H; Ozawa K; Inaba T
    Mol Cell Biol; 2004 Jul; 24(14):6172-83. PubMed ID: 15226421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the anti-apoptotic effects of Bcr-Abl, Bcl-2 and Bcl-x(L) following diverse apoptogenic stimuli.
    Brumatti G; Weinlich R; Chehab CF; Yon M; Amarante-Mendes GP
    FEBS Lett; 2003 Apr; 541(1-3):57-63. PubMed ID: 12706819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML).
    Desterke C; Voldoire M; Bonnet ML; Sorel N; Pagliaro S; Rahban H; Bennaceur-Griscelli A; Cayssials E; Chomel JC; Turhan AG
    Exp Hematol; 2018 Aug; 64():71-83.e8. PubMed ID: 29733872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation.
    Cirinnà M; Trotta R; Salomoni P; Kossev P; Wasik M; Perrotti D; Calabretta B
    Blood; 2000 Dec; 96(12):3915-21. PubMed ID: 11090078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides.
    Aichberger KJ; Mayerhofer M; Krauth MT; Skvara H; Florian S; Sonneck K; Akgul C; Derdak S; Pickl WF; Wacheck V; Selzer E; Monia BP; Moriggl R; Valent P; Sillaber C
    Blood; 2005 Apr; 105(8):3303-11. PubMed ID: 15626746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line.
    Ahmed M; Dusanter-Fourt I; Bernard M; Mayeux P; Hawley RG; Bennardo T; Novault S; Bonnet ML; Gisselbrecht S; Varet B; Turhan AG
    Oncogene; 1998 Jan; 16(4):489-96. PubMed ID: 9484838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells.
    Li QF; Huang WR; Duan HF; Wang H; Wu CT; Wang LS
    Oncogene; 2007 Dec; 26(57):7904-8. PubMed ID: 17599053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway.
    Kurosu T; Wu N; Oshikawa G; Kagechika H; Miura O
    Apoptosis; 2010 May; 15(5):608-20. PubMed ID: 20094798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
    Wang W; DU Y; Lin GQ; Li NN; Sun BZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CML and apoptosis: the ceramide pathway.
    Maguer-Satta V
    Hematol Cell Ther; 1998 Oct; 40(5):233-6. PubMed ID: 9844818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.
    Dai Y; Rahmani M; Corey SJ; Dent P; Grant S
    J Biol Chem; 2004 Aug; 279(33):34227-39. PubMed ID: 15175350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src, Akt, NF-κB, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia.
    Vázquez-Franco JE; Reyes-Maldonado E; Vela-Ojeda J; Domínguez-López ML; Lezama RA
    Leuk Res; 2012 Jul; 36(7):862-7. PubMed ID: 22591684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.